Thomas Willigenburg

Appendices 246 10. T. Willigenburg, D.M. de Muinck Keizer, M. Peters, A. Claes, J.J.W. Lagendijk, J.C.J. de Boer, J.R.N. van der Voort van Zyp. Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator. Clinical and Translational Radiation Oncology (2021). DOI: 10.1016/j.ctro.2021.01.002. 11. C. Zachiu, B. Denis de Senneville, T. Willigenburg, J.R.N. Voort van Zyp, J.C.J. de Boer, B.W. Raaymakers, M. Ries. Anatomically-adaptive multi-modal image registration for image-guided external-beam radiotherapy. Physics in Medicine and Biology (2020). DOI: 10.1088/1361-6560/abad7d. 12. D.M. de Muinck Keizer, L.G.W. Kerkmeijer, T. Willigenburg, A.L.H.M.W. van Lier, M.D. den Hartogh, J.R.N. van der Voort van Zyp, E.N. de Groot-van Breugel, B.W. Raaymakers, J.J.W. Lagendijk, J.C.J. de Boer. Prostate intrafraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5 T MR-Linac. Radiotherapy and Oncology (2020). DOI: 10.1016/j.radonc.2020.06.044. 13. C. Kontaxis, D.M. de Muinck Keizer, L.G..W Kerkmeijer, T. Willigenburg, M.D. den Hartogh, J.R.N. van der Voort van Zyp, E.N. de Groot-van Breugel, J. Hes, B.W. Raaymakers, J.J.W. Lagendijk, J.C.J. de Boer. Delivered dose quantification in prostate radiotherapy using online 3D cine imaging and treatment log files on a combined 1.5T magnetic resonance imaging and linear accelerator system. Physics and Imaging in Radiation Oncology (2020). DOI: 10.1016/j.phro.2020.06.005. 14. T. Willigenburg, E. Beld, J. Hes, J.J.W. Lagendijk, J.C.J. de Boer, M.A. Moerland, J.R.N. van der Voort van Zyp. Focal salvage treatment for radiorecurrent prostate cancer: A magnetic resonance-guided stereotactic body radiotherapy versus high-dose-rate brachytherapy planning study. Physics and Imaging in Radiation Oncology (2020). DOI: 10.1016/j.phro.2020.07.006. Conference proceedings 1. T. Willigenburg, J.M. van der Velden, C. Zachiu, F.R. Teunissen, J.J.W. Lagendijk, B.W. Raaymakers, J.C.J. de Boer, J.R.N. van der Voort van Zyp. Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided radiotherapy. Oral, MR-Linac consortium meeting 2022. 2. T. Willigenburg, C. Zachiu, G.H. Bol, E.N. de Groot-van Breugel, J.J.W. Lagendijk, J.R.N. van der Voort van Zyp, B.W. Raaymakers, J.C.J. de Boer. Feasibility of a sub-fractionation workflow for intrafraction replanning during prostate cancer SBRT on a 1.5 T MR-Linac. Oral, MR-Linac consortium meeting 2022. 3. F.R. Teunissen, T. Willigenburg, A.C. Tree, W.A. Hall, S.L. Choi, A. Choudhury, J.P. Christodouleas, J.C.J. de Boer, E.N. de Groot-van Breugel, L.G.W. Kerkmeijer, F.J. Pos, T. Schytte, D. Vesprini, H.M. Verkooijen, J.R.N. van der Voort van Zyp. Magnetic resonance guided adaptive radiotherapy for prostate cancer: the first results from the MOMENTUM study, an international registry for the evidence-based introduction of MR-guided radiotherapy. Oral, MR-Linac consortium meeting 2022. 4. T. Willigenburg, F.R. Teunissen, J.M. van der Velden, J.C.J. de Boer, J.R.N. van der Voort van Zyp. Patient-reported acute urinary toxicity after daily adaptive MR-guided SBRT for prostate cancer. Poster Discussion, ESTRO 2022. 5. F.R. Teunissen, T. Willigenburg, A.C. Tree, W.A. Hall, S.L. Choi, A. Choudhury, J.P. Christodouleas, J.C.J. de Boer, E.N. de Groot-van Breugel, L.G.W. Kerkmeijer, F.J. Pos, T. Schytte, D. Vesprini, H.M. Verkooijen, J.R.N. van der Voort van Zyp. Magnetic resonance guided adaptive radiotherapy for prostate cancer: the first results from the MOMENTUM study, an international registry for the evidence-based introduction of MR-guided radiotherapy. Poster, ESTRO 2022.

RkJQdWJsaXNoZXIy MTk4NDMw